Ultravin 37.5mg/325mg Tablet
Marketer
Vintas Pharmaceuticals Pvt. Ltd.
Salt Composition
Tramadol (37.5mg) + Paracetamol (325mg)
Overview Ultravin 37.5mg/325mg Tablet
Combiflex 37.5mg/325mg tablets offer dual pain relief for moderate to severe discomfort. Dosage and treatment length should strictly adhere to your physician's instructions. Consumption may be independent of meals, though food may alleviate potential stomach upset. Consistent dosing is crucial; discontinue only under your doctor's guidance. Potential side effects include nausea, vomiting, dry mouth, dizziness, and constipation, usually mild and transient. Report any rash or allergic reaction immediately. Pregnant women, those planning pregnancy, or breastfeeding mothers must consult their doctor before use.
Uses of Ultravin 37.5mg/325mg Tablet
Significant to intense pain
Major Benefits of Ultravin 37.5mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ultravin 37.5mg/325mg Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Ultravin 37.5mg/325mg Tablet:
- Nausea
- Vomiting
- Constipation
- Dizziness
- Dryness in mouth
- Sleepiness
- Diarrhea
- Abdominal pain
- Dyspepsia
- Flatulence
- Headache
- Trembling
- Anxiety
- Sleep disorder
- Itching
How to use Ultravin 37.5mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ultravin 37.5mg/325mg Tablet whole; do not break, crush, or chew it. While it can be taken with or without food, consistent timing is recommended.
How Ultravin 37.5mg/325mg Tablet works:
Each Ultravin 37.5mg/325mg tablet combines tramadol and paracetamol to effectively manage intense pain. Tramadol, an opioid analgesic, diminishes pain sensation by interrupting pain signals to the brain. Paracetamol acts by inhibiting the production of pain-inducing chemical mediators.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Ultravin 37.5mg/325mg Tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Ultravin 37.5mg/325mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Ultravin 37.5mg/325mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant. However, seek immediate medical attention if the baby exhibits excessive sleepiness, feeding difficulties, respiratory distress, or floppiness.
DrivingUNSAFE
Driving ability may be impaired by side effects of Ultravin 37.5mg/325mg tablets.
KidneyCAUTION
Patients with kidney impairment should use Ultravin 37.5mg/325mg tablets cautiously. Dosage modification of Ultravin 37.5mg/325mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Ultravin 37.5mg/325mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Ultravin 37.5mg/325mg tablets are contraindicated in individuals with severe or active liver disease.
What if you forget to take Ultravin 37.5mg/325mg Tablet :
Should you forget to take your Ultravin 37.5mg/325mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Ultravin 37.5mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Pain Relievers |
3,018 People bought this recently